We are committed to successful outcomes.
Call us today at 213-469-6277 to schedule a consultation.
We specialize in saving lives. We provide innovative care for unborn babies and compassionate support for families.
Conditions We Treat
- Acardiac Twins
- Alloimmune Thrombocytopenia
- Alloimmunization and Fetal Anemia
- Amniotic Band Syndrome
- Bronchopulmonary Sequestration
- Cardiac Abnormalities
- Chorioangioma
- Cystic Adenomatoid Malformation
- Congenital Diaphragmatic Hernia
- Iatrogenic Preterm Premature Membrane Rupture
- Lower Urinary Tract Obstruction
- Pleural Effusions
- Selective Intrauterine Growth Restrictions
- Spina Bifida/Myelomeningocele
- Twin-Twin Transfusion Syndrome
- Vasa Previa
Why Choose Us?
Innovative
Los Angeles Fetal Surgery offers innovative minimally invasive fetal surgery. We are one of only two centers in the United States that offers in-utero percutaneous repair of spina bifida. We integrate research into our practice to provide the most advanced care for our patients.
Collaborative
Due to our center’s collaborative structure, patients referred to the Fetal Surgery Program have access to a wide variety of services and specialists from Children’s Hospital Los Angeles, including cardiology, craniofacial, genetics, infectious disease, neonatology, neurology, neurosurgery, ophthalmology, orthopedics, otolaryngology, radiology, surgery, and urology.
Experience
Using a minimally invasive approach, our center performs over 150 fetal interventions per year. Dr. Chmait has served as our director since 2006. With 20 years of experience as a fetal surgeon, he has performed over 2000 fetal interventions, including over 1100 twin-twin transfusion syndrome cases, and has published over 190 peer-reviewed articles on the topic of fetal surgery.
Outcomes
Our center’s perinatal survivorship rates are among the highest reported in the medical literature. In our recently completed 12-year randomized controlled trial comparing sequential versus selective laser techniques, we achieved over 93% survival of at least one twin and 78% survival of both twins. The findings also suggest how two important factors—critically abnormal donor Dopplers and the presence of arterio-arterial anastomoses—can help guide selection of the optimal surgical approach.